Dr. Jay-Jiguang Zhu, MD
Claim this profileMemorial Hermann Texas Medical Center
Studies Glioblastoma
Studies Brain Tumor
8 reported clinical trials
32 drugs studied
Area of expertise
1Glioblastoma
MET negative
MET positive
Stage I
2Brain Tumor
H3 K27M positive
Affiliated Hospitals
Clinical Trials Jay-Jiguang Zhu, MD is currently running
DSC-MRI
for Recurrent Glioblastoma
This phase II trial studies how well dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) works in measuring relative cerebral blood volume (rCBV) for early response to bevacizumab in patients with glioblastoma that has come back. DSC-MRI may help evaluate changes in the blood vessels within the cancer to determine a patient?s response to treatment.
Recruiting1 award N/A
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
More about Jay-Jiguang Zhu, MD
Clinical Trial Related7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jay-Jiguang Zhu, MD has experience with
- Capivasertib
- Vismodegib
- ONC201
- Modified Lumbar Puncture
- Berubicin
- Lomustine
Breakdown of trials Jay-Jiguang Zhu, MD has run
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jay-Jiguang Zhu, MD specialize in?
Jay-Jiguang Zhu, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved MET negative patients, or patients who are MET positive.
Is Jay-Jiguang Zhu, MD currently recruiting for clinical trials?
Yes, Jay-Jiguang Zhu, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Jay-Jiguang Zhu, MD has studied deeply?
Yes, Jay-Jiguang Zhu, MD has studied treatments such as Capivasertib, Vismodegib, ONC201.
What is the best way to schedule an appointment with Jay-Jiguang Zhu, MD?
Apply for one of the trials that Jay-Jiguang Zhu, MD is conducting.
What is the office address of Jay-Jiguang Zhu, MD?
The office of Jay-Jiguang Zhu, MD is located at: Memorial Hermann Texas Medical Center, Houston, Texas 77030 United States. This is the address for their practice at the Memorial Hermann Texas Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.